Rohan Ganesh is a venture capital investor at Obvious Ventures who combines rare hands-on experience building medical AI products and EMR systems with investment expertise from leading biotech-focused funds like Verily Life Sciences and Northpond Ventures. He holds issued US patents for validating machine learning models in clinical settings and focuses his investments on what he calls generative science in medicine—AI that can generate new biological hypotheses and therapies rather than just analyze existing data. Rohan Ganesh is a venture capital investor at Obvious Ventures who combines rare hands-on experience building medical AI products and EMR systems with investment expertise from leading biotech-focused funds like Verily Life Sciences and Northpond Ventures. He holds issued US patents for validating machine learning models in clinical settings and focuses his investments on what he calls generative science in medicine—AI that can generate new biological hypotheses and therapies rather than just analyze existing data.